OTC · Biotechnology

PsyBio Therapeutics Corp (PSYBF) Stock

$0.00 OTC: PSYBF Healthcare

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders.

Valuation

MetricValue
Price$0.00
Market Cap$1275
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$0.01
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE250.00%
ROA—
ROCE272.65%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.38

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$0$0$-6.0M$-9.0M$-4.0M
Net Profit$0$0$-6.0M$-11.0M$-5.0M
EPS$-0.01$0.00$-0.20$-0.10$-0.04
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$0$0$0$4.0M$0
Total Liabilities$0$0$1.0M$1.0M$2.0M
Cash$0$0$0$0$0
Borrowings$0$0$0$0$0

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$0$0$-1.0M$-7.0M$-3.0M
Investing Cash Flow$0$0$0$-4.0M$4.0M
Financing Cash Flow$0$0$1.0M$-1.0M$0
Net Cash Flow$0$0$0$0$0
Free Cash Flow$0$0$-1.0M$-7.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.03
FCF Yield-269570.98%
Quick Ratio0.13
Interest Coverage-206.05
Return 1Y-90.00%
Return 3Y-99.96%
Return 5Y—

Ownership

Insiders Held6.27%
Institutions Held3.57%
Institutions Float Held3.81%
Institutional HolderSharesReport Date
AdvisorShares Investments, LLC2,994,8172024-12-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHFFArch Biopartners Inc. $0.61 +0.80% -22.19 $41.10M 0.00%
CRRVFCVR Medical Corp. $0.00 — 0.00 $1072 0.00%
CVALFCovalon Technologies Ltd. $1.54 +0.00% 36.52 $42.53M 6.88%
ELIXFElixxer Ltd. $0.03 +0.00% -0.14 $23.35M 0.00%
HBPCFHelix BioPharma Corp. $1.71 +0.00% -32.27 $130.61M 0.00%

About PsyBio Therapeutics Corp

PsyBio Therapeutics Corp. engages in the development of drugs intended for the treatment of mental health challenges and other disorders. The company was founded on October 28, 2009 and is headquartered in Sunrise, FL.

PsyBio Therapeutics Corp (PSYBF) stock trades at $0.00 with a market capitalization of $1275. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.01, and currently trades 100.0% below its 52-week high.

On profitability, PsyBio Therapeutics Corp generates a return on equity (ROE) of 250.00% — well above the market average, a sign of a high-quality business, return on capital employed of 272.65%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.psybiolife.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides